Characterization of betaine aldehyde dehydrogenase (BetB) as an essential virulence factor of Brucella abortus

详细信息    查看全文

• 作者：Jin Ju Lee ; Jae Hong Kim ; Dae Geun Kim ; Dong Hyeok Kim ; Hannah Leah Simborio ; Won Gi Min ; Man Hee Rhee ; Jong Hwan Lim ; Hong Hee Chang ; Suk Kim
• 关键词：B. abortus ; betB ; Virulence ; Phagocyte ; Phagocytic pathway
• 刊名：Veterinary Microbiology
• 出版年：10 January, 2014
• 年：2014
• 卷：168
• 期：1
• 页码：131-140
• 全文大小：1423 K

文摘

The pathogenic mechanisms of Brucellosis used to adapt to the harsh intracellular environment of the host cell are not fully understood. The present study investigated the in vitro and in vivo characteristics of B. abortus betaine aldehyde dehydrogenase (BetB) (Gene Bank ID: 006932) using a betB deletion mutant constructed from virulent B. abortus 544. In test under stress conditions, including osmotic- and acid stress-resistance, the betB mutant had a lower osmotic-resistance than B. abortus wild-type. In addition, the betB mutant showed higher internalization rates compared to the wild-type strain; however, it also displayed replication failures in HeLa cells and RAW 264.7 macrophages. During internalization, compared to the wild-type strain, the betB mutant was more adherent to the host surface and showed enhanced phosphorylation of protein kinases, two processes that promote phagocytic activity, in host cells. During intracellular trafficking, colocalization of B. abortus-containing phagosomes with LAMP-1 was elevated in betB mutant-infected cells compared to the wild-type cells. In mice, the betB mutant was predominantly cleared from spleens compared to the wild-type strain after 2 weeks post-infection, and the vaccination test with the live betB mutant showed effective protection against challenge infection with the virulent wild-type strain. These findings suggested that the B. abortus betB gene substantially affects the phagocytic pathway in human phagocytes and in host cells in mice. Furthermore, this study highlights the potential use of the B. abortus betB mutant as a live vaccine for the control of brucellosis.